434 related articles for article (PubMed ID: 25908179)
1. Rituximab for eosinophilic granulomatosis with polyangiitis with severe vasculitic neuropathy: Case report and review of current clinical evidence.
Fanouriakis A; Kougkas N; Vassilopoulos D; Fragouli E; Repa A; Sidiropoulos P
Semin Arthritis Rheum; 2015 Aug; 45(1):60-6. PubMed ID: 25908179
[TBL] [Abstract][Full Text] [Related]
2. Rituximab as Induction Therapy in Eosinophilic Granulomatosis with Polyangiitis Refractory to Conventional Immunosuppressive Treatment: A 36-Month Follow-Up Analysis.
Thiel J; Troilo A; Salzer U; Schleyer T; Halmschlag K; Rizzi M; Frede N; Venhoff A; Voll RE; Venhoff N
J Allergy Clin Immunol Pract; 2017; 5(6):1556-1563. PubMed ID: 28916432
[TBL] [Abstract][Full Text] [Related]
3. Rituximab in the treatment of refractory or relapsing eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome).
Thiel J; Hässler F; Salzer U; Voll RE; Venhoff N
Arthritis Res Ther; 2013 Sep; 15(5):R133. PubMed ID: 24286362
[TBL] [Abstract][Full Text] [Related]
4. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management.
Groh M; Pagnoux C; Baldini C; Bel E; Bottero P; Cottin V; Dalhoff K; Dunogué B; Gross W; Holle J; Humbert M; Jayne D; Jennette JC; Lazor R; Mahr A; Merkel PA; Mouthon L; Sinico RA; Specks U; Vaglio A; Wechsler ME; Cordier JF; Guillevin L
Eur J Intern Med; 2015 Sep; 26(7):545-53. PubMed ID: 25971154
[TBL] [Abstract][Full Text] [Related]
5. A rare case report of polyangiitis overlap syndrome: granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis.
Quan MV; Frankel SK; Maleki-Fischbach M; Tan LD
BMC Pulm Med; 2018 Nov; 18(1):181. PubMed ID: 30497438
[TBL] [Abstract][Full Text] [Related]
6. Rituximab as induction therapy in relapsing eosinophilic granulomatosis with polyangiitis: A report of 6 cases.
Novikov P; Moiseev S; Smitienko I; Zagvozdkina E
Joint Bone Spine; 2016 Jan; 83(1):81-4. PubMed ID: 26494587
[TBL] [Abstract][Full Text] [Related]
7. Multi-targeted therapy for refractory eosinophilic granulomatosis with polyangiitis characterized by intracerebral hemorrhage and cardiomyopathy: a case-based review.
Mutoh T; Shirai T; Sato H; Fujii H; Ishii T; Harigae H
Rheumatol Int; 2022 Nov; 42(11):2069-2076. PubMed ID: 34287685
[TBL] [Abstract][Full Text] [Related]
8. Successful use of Rituximab in a patient with recalcitrant multisystemic eosinophilic granulomatosis with polyangiitis.
Najem CE; Yadav R; Carlson E
BMJ Case Rep; 2015 May; 2015():. PubMed ID: 25979957
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of conventional immunosuppressants in relapsing or refractory eosinophilic granulomatosis with polyangiitis: evidence from a Canadian single-centre cohort.
Doubelt I; Pulenzas N; Carette S; Pagnoux C;
Clin Exp Rheumatol; 2020; 38 Suppl 124(2):171-175. PubMed ID: 32167871
[TBL] [Abstract][Full Text] [Related]
10. Rituximab in the treatment of eosinophilic granulomatosis with polyangiitis.
Muñoz SA; Gandino IJ; Orden AO; Allievi A
Reumatol Clin; 2015; 11(3):165-9. PubMed ID: 25523986
[TBL] [Abstract][Full Text] [Related]
11. Severe cardiomyopathy revealing antineutrophil cytoplasmic antibodies-negative eosinophilic granulomatosis with polyangiitis.
Bouiller K; Samson M; Eicher JC; Audia S; Berthier S; Leguy V; Humbert O; Martin L; Lorgis L; Cottin Y; Bonnotte B; Lorcerie B
Intern Med J; 2014 Sep; 44(9):928-31. PubMed ID: 25201426
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Eosinophilic Granulomatosis with Polyangiitis: A Review.
Raffray L; Guillevin L
Drugs; 2018 Jun; 78(8):809-821. PubMed ID: 29766394
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of rituximab in the treatment of eosinophilic granulomatosis with polyangiitis.
Teixeira V; Mohammad AJ; Jones RB; Smith R; Jayne D
RMD Open; 2019; 5(1):e000905. PubMed ID: 31245051
[TBL] [Abstract][Full Text] [Related]
14. Polyangiitis overlap syndrome of granulomatosis with polyangiitis (Wegener's granulomatosis) and eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome).
Uematsu H; Takata S; Sueishi K; Inoue H
BMJ Case Rep; 2014 Feb; 2014():. PubMed ID: 24577169
[TBL] [Abstract][Full Text] [Related]
15. Rituximab for eosinophilic granulomatosis with polyangiitis: a systematic review of observational studies.
Menditto VG; Rossetti G; Olivari D; Angeletti A; Rocchi M; Gabrielli A; Pomponio G
Rheumatology (Oxford); 2021 Apr; 60(4):1640-1650. PubMed ID: 33471122
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic advances in eosinophilic granulomatosis with polyangiitis.
Ford JA; Aleatany Y; Gewurz-Singer O
Curr Opin Rheumatol; 2022 May; 34(3):158-164. PubMed ID: 35440531
[TBL] [Abstract][Full Text] [Related]
17. Advances in the pharmacotherapeutic management of eosinophilic granulomatosis with polyangiitis.
Pagnoux C; Berti A
Expert Opin Pharmacother; 2023; 24(11):1269-1281. PubMed ID: 37204027
[TBL] [Abstract][Full Text] [Related]
18. Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis: A systematic literature review.
Akiyama M; Kaneko Y; Takeuchi T
Autoimmun Rev; 2021 Feb; 20(2):102737. PubMed ID: 33340770
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of eosinophilic granulomatosis with polyangiitis (EGPA; formerly Churg-Strauss syndrome) with rituximab in a case refractory to glucocorticoids, cyclophosphamide, and IVIG.
Umezawa N; Kohsaka H; Nanki T; Watanabe K; Tanaka M; Shane PY; Miyasaka N
Mod Rheumatol; 2014 Jul; 24(4):685-7. PubMed ID: 24517553
[TBL] [Abstract][Full Text] [Related]
20. Sequential rituximab and omalizumab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome).
Aguirre-Valencia D; Posso-Osorio I; Bravo JC; Bonilla-Abadía F; Tobón GJ; Cañas CA
Clin Rheumatol; 2017 Sep; 36(9):2159-2162. PubMed ID: 28762062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]